The global epidemiology of diabetes and kidney disease

DN Koye, DJ Magliano, RG Nelson… - Advances in chronic kidney …, 2018 - Elsevier
The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in
low-and middle-income countries. In most developed countries, type 2 diabetes is presently …

Chronic kidney disease and SGLT2 inhibitors: a review of the evolving treatment landscape

CW Mende - Advances in therapy, 2022 - Springer
There is currently an unmet need for effective treatment of chronic kidney disease (CKD) that
slows disease progression, prevents development of end-stage kidney disease and …

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

G Schernthaner, N Shehadeh, AS Ametov… - Cardiovascular …, 2020 - Springer
The disclosure of proven cardiorenal benefits with certain antidiabetic agents was supposed
to herald a new era in the management of type 2 diabetes (T2D), especially for the many …

Albuminuria and Heart Failure: JACC State-of-the-Art Review

MS Khan, I Shahid, SD Anker, GC Fonarow… - Journal of the American …, 2023 - jacc.org
Although chronic kidney disease is characterized by low glomerular filtration rate (GFR) or
albuminuria, estimated GFR (eGFR) is more widely utilized as a marker of risk profile in …

Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 US health care organizations

N Stempniewicz, JA Vassalotti, JK Cuddeback… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE Clinical guidelines for people with diabetes recommend chronic kidney disease
(CKD) testing at least annually using estimated glomerular filtration rate (eGFR) and urinary …

The next generation of therapeutics for chronic kidney disease

MD Breyer, K Susztak - Nature reviews Drug discovery, 2016 - nature.com
Chronic kidney disease (CKD) represents a leading cause of death in the United States.
There is no cure for this disease, with current treatment strategies relying on blood pressure …

The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low-and middle-income countries—a review of the current …

C George, JB Echouffo-Tcheugui, BG Jaar, IG Okpechi… - BMC medicine, 2022 - Springer
Chronic kidney disease (CKD) in people with diabetes is becoming an increasing major
public health concern, disproportionately burdening low-and middle-income countries …

Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD …

N Tangri, T Moriyama, MP Schneider, JB Virgitti… - BMJ open, 2023 - bmjopen.bmj.com
Objectives REVEAL-CKD aims to estimate the prevalence of, and factors associated with,
undiagnosed stage 3 chronic kidney disease (CKD). Design Multinational, observational …

Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice

J Jitraknatee, C Ruengorn, S Nochaiwong - Scientific reports, 2020 - nature.com
This cross-sectional study aimed to investigate the prevalence and risk factors of chronic
kidney disease (CKD) among 1,096 primary care type 2 diabetes (T2DM) patients in …

Chronic kidney disease testing among at-risk adults in the US remains low: real-world evidence from a national laboratory database

D Alfego, J Ennis, B Gillespie, MJ Lewis… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE An estimated 37 million Americans have chronic kidney disease (CKD). Nearly
90% do not know about their condition because of low awareness about the importance of …